FDA Will Define Preclinical Testing Requirements For Drug-Coated Stents
This article was originally published in The Gray Sheet
Executive Summary
Preclinical data requirements for drug-eluting stent sponsors will be addressed in a forthcoming FDA guidance. Items to be covered include material analysis, integrity and fatigue testing, stent/catheter system testing, and animal testing, according to Center for Devices and Radiological Health reviewers.